OasisLMS

This OnDemand Learning Experience is included as part of registration for the 2026 HFSA AHFTC Board Certification Review, held July 17–18, 2026.

If you did not register for the live course, you may purchase the 2026 AHFTC Board Certification Review – OnDemand separately through the HFSA Learning Center.

As a registered attendee of the 2026 HFSA AHFTC Board Certification Review held July 17–18, 2026, your registration includes complimentary access to this OnDemand Learning Experience.

This course provides the pre-meeting preparation modules, recordings from the live Board Certification Review, study resources, and continuing education activities to support your preparation for the ABIM Advanced Heart Failure and Transplant Cardiology Certification Examination and your ongoing clinical practice.

• Cardio-Oncology for the HF Boards - Bonnie Ky 
• Clinico-Pathologic Correlates in Heart Failure/ Images for the Heart Failure Boards - Jon Lomasney 
• DM, Obesity/CKM - Amanda Vest 
• Diagnosis and Clinical Assessment - Mark Drazner 
• Healthcare Disparities in HF - Khadijah Breathett 
• Heart Failure Epidemiology and Risk Factors - Clyde Yancy 
• Hemodynamics in HF Virtural - James C. Fang 
• Issues in Chronic HF Disease Management (Biomarkers, Remote Monitoring, Lifestyle Interventions) - Akshay Desai 
• Management of Comorbidities in Heart Failure - Sleep Disorders  - Robert Mentz 
• Optimal Medical Therapy for HFrEF Virtual - Mark Drazner 
• Pathophysiology 1: Cellular and Energetic Considerations - Daniel Burkhoff 
• Pathophysiology 2: Hemodynamic, Structural and Neurohormonal Considerations - Daniel Burkhoff 
• Pulmonary Hypertension - Classification and Initial Evaluation - Yasmin Raza 
• Pulmonary Hypertension – Treatment - Yasmin Raza 
• RV Failure and TR Management - Barry Borlaug 
• Statistics for the HF Board - Brian Claggett 

Presentation slides are now available for download.

The recorded presentations from the live 2026 HFSA AHFTC Board Certification Review will be added to this course as they become available. Recordings will be uploaded on an ongoing basis as they are received.

• Hemodynamics in HF Live - James C. Fang 
• Optimal Medical Therapy for HFrEF Live - Mark Drazner 
• Cardio Renal Failure Interactions in Heart Failure - Wendy McCallum 
• Assessment of Functional Capacity including cardiopulmonary exercise testing - Gregory Lewis 
• HFpEF: Epidemiology, Risk Factors, Diagnosis, Management (For the Boards) - Ravi Patel 
• Management of Comorbidities in Heart Failure: Iron Deficiency/Anemia - Gregory Lewis 
• Specific Etiologies of HF 1: HCM - Jane Wilcox 
• Specific Etiologies of HF 2: Other Inherited HF syndromes - Jane Wilcox
• Specific Etiologies of HF 3: Infiltrative Disorders and Restrictive CMP - Jennifer Cowger
• Specific Etiologies of HF 4: Myocarditis and Inflammatory Cardiomyopathies - Jennifer Cowger 
• Management of the Hospitalized HF Patient - Alpesh Amin 
• Management of Left Sided Valvular Heart Disease in Heart Failure - Jane Wilcox 
• Management of Common Arrhythmias 1 & 2 - Susan Kim 
• Adult Congenital Heart Disease for the HF Specialist - Eric Krieger 
• Pregnancy in HF - Sarah Goldstein 
• Immunology: The Basics, PRA, Sensitization, Crossmatch - Palak Shah 
• Rejection: Cellular and Antibody Mediated - Palak Shah 
• Heart Transplant, Clinical Outcomes and Complications - Michelle Kittleson 
• Managing Immunosuppression and Drugs - Michelle Kittleson 
• Advanced Heart Failure: Defining the Phenotype and Patient Selection for Advanced Therapies - Mark Belkin 
• Cardiogenic Shock Management - Esther Vorovich 
• Device Therapy in Heart Failure I - Sudden Death Prevention - Theofanie Mela 
• Device Therapy in Heart Failure II - CRT - Theofanie Mela 
• MCS 1: Durable MCS Devices and Outcomes - Jennifer Cowger 
• MCS 2: Temporary Support Devices and ECMO for the Boards - Shashank Sinha 
• MCS 3: Management of complications of MCS - Shashank Sinha 
• MCS 4: Interactive Shock and Device Management - Daniel Burkhoff

Practice with board-style examination questions
Test your knowledge with board-style practice questions.  Reinforce your understanding of key concepts through exam-style multiple-choice questions developed by leading heart failure experts and aligned with the official ABIM Advanced Heart Failure and Transplant Cardiology (AHFTC) examination blueprint. Each question includes detailed explanations to help identify knowledge gaps, strengthen clinical reasoning, and build confidence for exam day. 

You are allowed two resets of the exam, before you can access the rationale and the correct response

Reading List
Study the essential literature that supports board success.  The curated Reading List features landmark clinical trials, current practice guidelines, scientific statements, and foundational articles selected by the course faculty. Use these resources to deepen your understanding of advanced heart failure and transplant cardiology while reinforcing the topics covered throughout the Board Review course. 

Can I earn continuing education credit?
Yes. Eligible learners may claim CME, NCPD, and ABIM MOC credit upon successful completion of the course requirements.

How do i claim continuing education credit?
Complete the course evaluation to help us improve future educational programs. Once the evaluation is submitted, you can generate your certificate and transcript by returning to your Catalog and selecting Transcript from the left navigation menu.

Are presentation slides included?
Presentation slides are available for download.

Will the live sessions be recorded and available for viewing?
The recorded presentations from the live 2026 HFSA AHFTC Board Certification Review will be added to as they become available. Recordings will be uploaded on an ongoing basis as they are received. 

Can I retake the practice examination?
Yes. The question bank may be reset up to two times before answer rationales become available.

In support of improving patient care, The Heart Failure Society of America is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The Heart Failure Society of America designates this educational activity for a maximum of 23.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 
  
Successful completion of this activity, which includes participation in the evaluation component and post-test with 75% passing score, enables the participant to earn up to 23.50 MOC contact hours in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program.

This educational activity is approved for nursing continuing professional development (NCPD) units by the Heart Failure Society of America. This activity is approved for a maximum of 23.50 NCPD contact hours. 

Learners should claim only the credit commensurate with the extent of their participation in the activity. 

This course is designed to:
1.    Review testable content and the focus of the ABIM Advanced Heart Failure and Transplant Cardiology Certification Examination.
2.    Identify gaps in knowledge about advanced heart failure and transplant cardiology.  
3.    Explain how to best focus study efforts on filling identified knowledge gaps.  
4.    Provide practice for the certification examination with ABIM-style multiple-choice test questions.

1. Describe the epidemiology of heart failure, including environmental factors, and implement strategies for the prevention of heart failure.
2. Discuss the pathophysiology of heart failure, including normal physiology and compensatory and maladaptive mechanisms.
3. Assess and treat patients with acute or advanced heart failure, using non-invasive and invasive tests and biomarkers.
4. Apply guideline-based therapy for patients with chronic heart failure, including pharmacologic agents; non-pharmacologic options, such as diet and exercise; and implantable devices.
5. Incorporate appropriate care strategies for patients undergoing chemotherapy or with pulmonary hypertension, heart failure with preserved ejection fraction, valvular heart disease, pregnancy-associated disease, and cardiorenal syndrome.
6. Explain the genetic basis of cardiomyopathies, including hypertrophic cardiomyopathy, and recognize when to pursue genetic testing as part of the evaluation of patients with suspected inherited heart failure syndromes.
7. Manage comorbidities in patients with chronic heart failure, including sleep-disordered breathing, anemia, and diabetes.
8. Implement strategies for effective disease management of patients with advanced heart failure, including referral for mechanical circulatory support, heart transplant, or palliative care.
9. Manage immunosuppressive therapies and common complications of heart transplant, including rejection, allograft vasculopathy, and immunosuppression-associated conditions.
10. Utilize mechanical support devices, both temporary and durable.
11. Manage common complications of mechanical circulatory support.